Cambria Investment Management, L.P.
Position in MRK — Merck & Co., Inc.
CIK 1529389
Manhattan Beach, CA
Position in MRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,422,366
+$547,858 QoQ
Shares Held
11,069
+52.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,832
of 3,778 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cambria Investment Management, L.P. holds $25,681,902 across 10 Drug Manufacturers - General names. MRK ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
429,762 | $10,348,668 | |
| 2 | LLY |
ELI LILLY & Co
|
4,161 | $4,990,828 | |
| 3 | ABBV |
AbbVie Inc.
|
11,859 | $2,984,198 | |
| 4 | JNJ |
Johnson & Johnson
|
7,734 | $1,964,203 | |
| 5 | AMGN |
Amgen Inc
|
5,093 | $1,844,277 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
11,069 | $1,422,366 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,599 | $960,057 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
9,573 | $551,596 |
All Filings in MRK
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,422,366 | 11,069 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $874,508 | 7,270 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $634,086 | 6,024 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||